Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Flu Vaccine Production Down Slightly This Season; Strains Get Overhaul

Executive Summary

FDA encourages people to get vaccinations since two of the three virus strains in this season’s flu vaccines differ from last season’s; several manufacturers plan to distribute slightly fewer doses in 2012-2013 than in the prior year.

You may also be interested in...

Flu Vaccine Strain Selection Gets An Overhaul As Effectiveness “Crisis” Looms

The non-H1N1 components of this season’s influenza vaccine will be replaced for 2013-2014 as public health officials hope for a better match next season in order to improve performance.

Novartis’ Cell-based Vaccine: Seasonal Approval With Pandemic Implications

The Flucelvax flu vaccine is the first approved in the U.S. that is derived from cell-based technology instead of the traditional egg-based process. It will be made at Novartis’ Holly Springs, N.C. plant.

Flu Vaccine Demand Forecast: Flat Or Up Slightly Compared With Last Year

The five providers of the six approved seasonal influenza vaccines appear to be preparing for a similar season with similar sales in 2011-12 as they had last year.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts